Newcomer Lee Nisley — SEC Form 4 filings

SEC reporting owner CIK 1788981. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-09.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-05-15 to 2026-06-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MYRIAD GENETICS INC (MYGN)Director41 leg · 6,200 sh · $156,8603
Coherus Oncology, Inc. (CHRS)Director34

Form 4 filings — Newcomer Lee Nisley

FiledFormIssuerReported transactionsSource
2026-06-094Coherus Oncology, Inc. (CHRS)Grant/award (A): 30,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2026-06-054MYRIAD GENETICS INC (MYGN)Grant/award (A): 59,701 @ $0EDGAR
2025-06-134Coherus Oncology, Inc. (CHRS)Grant/award (A): 112,000 (derivative) @ $0EDGAR
2025-06-064MYRIAD GENETICS INC (MYGN)Grant/award (A): 49,796 @ $0EDGAR
2024-06-074MYRIAD GENETICS INC (MYGN)Grant/award (A): 15,695 @ $0EDGAR
2024-06-054Coherus BioSciences, Inc. (CHRS)Grant/award (A): 112,000 (derivative) @ $0EDGAR
2024-05-154MYRIAD GENETICS INC (MYGN)Sale (S): 6,200 @ $25.30EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1788981 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →